The Pharma Data

JANUARY 12, 2021

13, 2021 /PRNewswire/ — Adastra Pharmaceuticals, Inc., About Adastra Pharmaceuticals. Adastra Pharmaceuticals Inc. Our vision is to identify, develop and deliver to patients important new therapies for diseases with significant unmet need. . PRINCETON, N.J. ,

Clinical Trials 52

Clinical Trials Trials Treatment Pharmaceuticals 52

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research 98

Clinical Research Clinical Development Pharmaceutical Companies Drug Development 98

The Pharma Data

JANUARY 27, 2021

28, 2021 /PRNewswire/ — CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.). A total of 15 patients have been recruited to date in the Phase I dose escalation part of the study, all of whom were late stage and have failed conventional treatments, including several lines of rituximab-containing therapies.

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Licensing Licensing 52

PPD

OCTOBER 12, 2023

Cell and gene therapies (CGTs) are one of the fastest growing areas in human therapeutics. Since chimeric antigen receptor T cell (CAR-T) therapy was first approved in 2017, there has been a marked increase of cell and gene therapy studies resulting in significant changes in the way diseases are treated as well as patient outcomes.

Laboratories 52

Laboratories Protein Expression Clinical Trials Pharmacokinetics 52

The Pharma Data

DECEMBER 16, 2020

17, 2020 /PRNewswire/ — CNS Pharmaceuticals, Inc. The Company will initiate its trial during the first quarter of 2021 to investigate the efficacy of Berubicin in adults with GBM who have failed first-line therapy. About CNS Pharmaceuticals, Inc. SOURCE CNS Pharmaceuticals, Inc.

FDA Approval 52

FDA Approval FDA Pharmaceuticals Clinical Trials 52

Drug Channels

MAY 9, 2022

Attorney’s Office, District of New Jersey Lauren Powell, MPA, PhD, Vice President, US Health Equity & Community Wellness, Takeda Pharmaceuticals PLUS! Download the full agenda and save your seat today! Cortes, Executive Assistant U.S. Attorney, U.S.

Specialty Pharmacies 69

Specialty Pharmacies Pharmacy Pharmaceuticals Government 69

The Pharma Data

JANUARY 7, 2021

To view the full announcement, including downloadable images, bios, and more, click here. The unique testing platform combines machine learning, automation and high-throughput screening directly on patient samples to predict responses to potential therapies and ultimately determine which therapies will be most effective for specific cancers.

Pharmaceutical Companies 52

Pharmaceutical Companies Therapies Science Pharmaceuticals 52

The Pharma Data

JANUARY 9, 2021

10, 2021 /PRNewswire/ — BioMarin Pharmaceutical Inc. NASDAQ: BMRN) today announced positive topline results from its ongoing global Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy for the treatment of adults with severe hemophilia A. . SAN RAFAEL, Calif. , GENEr8-1 Study Description.

Therapies 52

Therapies Trials Clinical Trials Treatment 52

The Pharma Data

OCTOBER 26, 2020

27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” About Aridis Pharmaceuticals, Inc. Aridis Pharmaceuticals, Inc. SAN JOSE, Calif. ,

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

Drug Channels

OCTOBER 19, 2020

You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/trade-channel for further details and to register. Visit www.informaconnect.com/trade-channel for further details and to register.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

Drug Channels

NOVEMBER 8, 2020

You can download the complete agenda here. Visit www.informaconnect.com/trade-channel for further details and to register. Drug Channels readers will save $200 off the standard rate when they use code KTP933 and register prior to November 20th.*. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

Drug Channels

OCTOBER 26, 2020

You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/gtn for further details and to register.

Government 40

Government Pharmaceuticals Science Production 40

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Or, download this spreadsheet and email your registrants’ information to Tamra Feldman ( admin@drugchannels.net ).

Pharmacy 72

Pharmacy Drugs Marketing Therapies 72

PPD

OCTOBER 31, 2024

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. Furthermore, the development of innovative therapies often necessitates intricate protocols, adding layers of complexity to trial management.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

The Pharma Data

JANUARY 13, 2021

“Receiving Fast Track designation is an important acknowledgment of the results of our COVID-19 laboratory research,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded at the link below. Source link.

Clinical Trials 52

Clinical Trials Trials Treatment FDA 52

The Pharma Data

MAY 4, 2021

INDIANAPOLIS , May 4, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 therapies at no cost to low- and lower-middle-income countries most heavily impacted by the pandemic. It is approved in the U.S.

Therapies 52

Therapies Hospitals Treatment FDA Approval 52

The Pharma Data

JANUARY 6, 2021

Quantitative imaging of CD8 T cells enables quicker identification of drug efficacy, therefore potentially reducing the length of clinical trials, reducing costs and helping new therapies to advance to market faster, which ultimately will improve treatment and care of cancer patients. View original content to download multimedia: [link].

Licensing 52

Licensing Licensing Clinical Trials Pharmaceutical Companies 52

The Pharma Data

AUGUST 19, 2020

19, 2020 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. Momenta), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 NEW BRUNSWICK, N.J. ,

Disease 40

Disease Pharmaceuticals Treatment Pharmaceutical Companies 40

The Pharma Data

JANUARY 20, 2021

21, 2021 /PRNewswire/ — Dynacure , a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, announced today the appointment of Jean M. View original content to download multimedia: [link]. Previously, Ms.

Treatment 52

Treatment Pharmaceuticals Drug Development Science 52

The Pharma Data

MAY 4, 2021

Lilly is offering donations of baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic.

Licensing 40

Licensing Licensing Therapies Laboratories 40

The Pharma Data

OCTOBER 19, 2020

Value-based agreements, like that with Biogen, can lower costs for payers, offer pharmaceutical companies valuable feedback about their therapies, and, ultimately, have the potential to reduce the cost and improve the quality of healthcare. View original content to download multimedia: [link].

Production 40

Production Pharmacy Pharmaceutical Companies Therapies 40

The Pharma Data

DECEMBER 28, 2020

Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. Dr. Russell has extensive leadership experience across diverse disciplines at numerous private and public biopharmaceutical, biotechnology and pharmaceutical companies. David S.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Government Therapies 52

The Pharma Data

JANUARY 22, 2021

Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals’ Lupkynis TM (voclosporin) as the first oral treatment developed specifically for adults with active lupus nephritis (LN) in combination with standard of care. Click here for the announcement from Aurinia Pharmaceuticals Inc.

Research 52

Research Treatment FDA Approval Disease 52

The Pharma Data

JANUARY 13, 2021

. Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development Officer. ” MindMed Chief Development Officer Rob Barrow said, “Psychedelic therapies offer a once in a lifetime opportunity to revolutionize the delivery of mental healthcare.

Clinical Trials 52

Clinical Trials FDA Trials Production 52

The Pharma Data

NOVEMBER 3, 2020

m (-), including US launch of the scientifically proven digital therapies deprexis® and vorvida®. Infringement litigation against Sun Pharmaceutical was commenced in response to Sun Pharmaceutical, that has filed an Abbreviated New Drug Application with the US FDA for ZUBSOLV® in the US. m (90.9).

Therapies 52

Therapies Production Pharmaceuticals Marketing 52

The Pharma Data

NOVEMBER 25, 2020

BioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of hematological cancer and solid tumors, respectively. About BioInvent. SOURCE BioInvent.

Clinical Trials 52

Clinical Trials Licensing Licensing International 52

The Pharma Data

OCTOBER 20, 2020

About Oncopeptides Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The following files are available for download: View original content: [link]. The information was submitted for publication at 08.30 CET on October 21, 2020.

Pharmaceutical Companies 52

Pharmaceutical Companies Treatment FDA Therapies 52

The Pharma Data

JANUARY 13, 2021

. From Lonza’s first manufacturing site for biologics in China , the healthcare leader will provide services and manufacturing needed to respond to growing global pharmaceutical needs. View original content to download multimedia: [link]. AMERSHAM, United Kingdom , Jan. 1 Source: [link]. SOURCE Cytiva.

Science 52

Science Therapies Marketing Pharmaceuticals 52

The Pharma Data

DECEMBER 8, 2020

BioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of hematological cancer and solid tumors, respectively. About BioInvent. www.bioinvent.com.

Clinical Trials 40

Clinical Trials Licensing Licensing International 40

The Pharma Data

DECEMBER 15, 2020

TOMI-T1D is an international partnership between academia, the pharmaceutical industry and nonprofit organizations. We collaborate with academic institutions, policymakers and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. About Diamyd Medical.

Drug Development 40

Drug Development Clinical Trials Trials Vaccine 40

The Pharma Data

JANUARY 19, 2021

BioInvent’s management team will also give an update on the ongoing Phase I/IIa trial of BI-1206 in combination with rituximab and BioInvent’s partner CASI Pharmaceuticals (NASDAQ: CASI) will provide an update on the development plan and potential for BI-1206 in China. About BioInvent. SOURCE BioInvent. Source link.

Clinical Trials 40

Clinical Trials Licensing Licensing International 40

The Pharma Data

OCTOBER 18, 2020

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The following files are available for download: View original content: [link]. The information was submitted for publication on October 19, 2020 at 08:30 (CET). About Oncopeptides.

FDA 40

FDA Drugs Pharmaceutical Companies Treatment 40

The Pharma Data

DECEMBER 17, 2020

Camurus’ clinical pipeline includes products for the treatment of cancer, endocrine diseases, pain and addiction, which are developed in-house and in collaboration with international pharmaceutical companies. The following files are available for download: View original content: [link]. For more information, visit camurus.com.

Treatment 52

Treatment Clinical Trials International Pharmaceutical Companies 52

The Pharma Data

MAY 4, 2021

Multiple sclerosis (MS), for example, is a condition for which timely diagnosis, early treatment and the development of innovative therapies are particularly important for reducing the disabling progress of the disease. Amid the coronavirus pandemic, concern has grown over the potential neglect of other serious diseases.

Disease 52

Disease Treatment Therapies Vaccine 52

The Pharma Data

JANUARY 31, 2021

About Orexo Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health. The following files are available for download: View original content: [link]. The products are commercialized by Orexo in the US or via partners worldwide.

Production 40

Production Marketing Regulations Therapies 40

The Pharma Data

JANUARY 6, 2021

“We are leveraging our strengths in process development and manufacturing for a wide range of biopharmaceuticals such as antibodies, recombinant proteins, gene therapies and vaccines,” said Martin Meeson , chief executive officer at FUJIFILM Diosynth Biotechnologies. View original content to download multimedia: [link].

Packaging 52

Packaging Small Molecule Production FDA Approval 52

The Pharma Data

JANUARY 4, 2021

Despite the significant advances in therapeutics in recent years, the 5-year survival rate of AML remains at 25%–30%, which still represents a significant unmet medical need for therapies with more durable efficacy and a better safety profile. . SUZHOU, China and ROCKVILLE, Md. , ” Reference.

FDA 40

FDA Therapies Drugs Treatment 40